Icosavax Inc

NASDAQ:ICVX   3:59:52 PM EDT
3.23
+0.17 (+5.56%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)128.83M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.9 Million
Adjusted EPS-$0.55
See more estimates
10-Day MA$3.27
50-Day MA$5.35
200-Day MA$10.17
See more pivots

Icosavax Inc Stock, NASDAQ:ICVX

1930 Boren Avenue, Suite 1000, Seattle, Washington 98101
United States of America
Phone: +1.206.737.0085
Number of Employees: 34

Description

Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.